epiClinical is fictional. It is a portfolio demonstration by Adam Daniels. Its studies, sponsors, sites and enrolment figures are synthetic. The evidence behind its assumptions is real, and every number says how far it can be trusted.
EPI-620, Phase III. In planning
Chronic obstructive pulmonary disease with frequent exacerbations
LWR-620 against placebo to reduce exacerbations in COPD. Sponsor: Litware Respiratory (fictional), Respiratory.
Where EPI-620 stands on September 30th 2026
Randomised0of 706 needed
Sites open0of 0 planned
Median forecast finish–Deadline Jul 2029
FinishIn planningThe Plan tab sizes the sites needed to meet the deadline.Open the plan
EnrolmentNo sites yetNothing to judge until sites open.Open KPIs
SitesNo sites yetNothing to judge until sites open.Open Sites
KRIsNo sites yetNothing to judge until sites open.Open KRIs
QTLsNo sites yetNothing to judge until sites open.Open QTLs